Alyeska Investment Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,950,607
| Closed | -$2.2M | – | 686 |
|
|
2022
Q2 | $2.2M | Buy |
+1,950,607
| New | +$2.2M | 0.03% | 395 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 999 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 884 |
|
|
2020
Q3 | – | Sell |
-39,944
| Closed | -$1.7M | – | 623 |
|
|
2020
Q2 | $1.7M | Buy |
+39,944
| New | +$1.7M | 0.03% | 357 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 491 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 490 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 512 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 508 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 439 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 463 |
|
|
2018
Q3 | – | Sell |
-23,695
| Closed | -$963K | – | 515 |
|
|
2018
Q2 | $963K | Buy |
+23,695
| New | +$963K | 0.01% | 370 |
|
|
2015
Q4 | – | Sell |
-1,262
| Closed | -$917K | – | 480 |
|
|
2015
Q3 | $917K | Sell |
1,262
-183
| -13% | -$133K | 0.01% | 390 |
|
|
2015
Q2 | $1.17M | Buy |
1,445
+304
| +27% | +$246K | 0.01% | 375 |
|
|
2015
Q1 | $843K | Buy |
1,141
+84
| +8% | +$62.1K | 0.01% | 417 |
|
|
2014
Q4 | $712K | Buy |
+1,057
| New | +$712K | 0.01% | 401 |
|